InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-48.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Fitzpatrick Alexander A, Conseiller Juridique et Secrétaire. Insider active across 3 companies, notably Evofem Biosciences, Inc.. Cumulatively, 11 disclosures have been published. Split: 5 buys · 0 sell. Total volume traded: €171k. History available since 20 May 2021. The latest transaction was disclosed on 20 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
100,000 shares@ US$5.5878.3% of flowCommon StockSEC:0001415889-25-014186:0
40,000 shares@ US$3.62421.7% of flowCommon StockSEC:0001209191-23-051073:0
Ideal exit: 24 Jun 2024 (T+270)
300,000 shares0Common StockSEC:0001618835-22-000031:0
120,000 shares0Common StockSEC:0001618835-22-000006
120,000 shares0Common StockSEC:0001618835-22-000006:0
▲
25,000 shares@ US$0.3891.00% mcap9.3% of flowCommon StockSEC:0001618835-21-000273:0
Ideal exit: 16 Sept 2022 (T+270)
▲
25,000 shares@ US$0.3899.3% of flowCommon StockSEC:0001618835-21-000273
Ideal exit: 16 Sept 2022 (T+270)
▲
10,000 shares@ US$1.0259.0% of flowCommon StockSEC:0001618835-21-000146
Ideal exit: 7 Mar 2022 (T+270)
▲
10,000 shares@ US$1.0250.98% mcap9.0% of flowCommon StockSEC:0001618835-21-000146:0
Ideal exit: 7 Mar 2022 (T+270)
●
42,120 shares@ US$0.8631.7% of flowCommon StockSEC:0001618835-21-000137
●
42,120 shares@ US$0.863.44% mcap31.7% of flowCommon StockSEC:0001618835-21-000137:0
11 of 11 declarations
About Fitzpatrick Alexander A
Alexander A. Fitzpatrick serves as General Counsel and Secretary for Evofem Biosciences, Inc. In this role, he is responsible for the company's legal matters and compliance. His expertise in corporate law is essential to ensure good governance at Evofem.
